Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease

Despite the continued development of cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs for the treatment of cystic fibrosis (CF), the need for mutation agnostic treatments remains. In a sub-group of CF individuals with mutations that may not respond to modulators, such as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez Loza, Laura I., Yuen, Eric C., McCray, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471883/
https://www.ncbi.nlm.nih.gov/pubmed/30875857
http://dx.doi.org/10.3390/genes10030218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471883/
https://www.ncbi.nlm.nih.gov/pubmed/30875857
http://dx.doi.org/10.3390/genes10030218

Ejemplares similares